⌘K

Login Start Free

Home/Filings/4/0001628280-21-012169

4//SEC Filing

ADAMS THOMAS PHD 4

Accession 0001628280-21-012169

CIK 0001213037other

View on SEC.gov Company Profile

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 4:10 PM ET

Size

18.1 KB

Accession

0001628280-21-012169

Insider Transaction Report

Form 4

Period: 2021-06-10

Cardiff Oncology, Inc.CRDF

ADAMS THOMAS PHD

Director

Transactions

Other
Stock Options
2021-06-10+173,145→ 477,870 total
Exercise: $2.60From: 2020-12-29Exp: 2023-06-10→ Common Stock (173,145 underlying)
Other
Stock Options
2021-06-10+223→ 477,870 total
Exercise: $5.18From: 2017-01-04Exp: 2023-06-10→ Common Stock (223 underlying)
Other
Stock Options
2021-06-10+272→ 477,870 total
Exercise: $447.84Exp: 2023-06-10→ Common Stock (272 underlying)
Other
Stock Options
2021-06-10+223→ 477,870 total
Exercise: $7.18From: 2016-03-17Exp: 2023-06-10→ Common Stock (223 underlying)
Other
Stock Options
2021-06-10+530→ 477,870 total
Exercise: $51.84From: 2018-10-04Exp: 2023-06-10→ Common Stock (530 underlying)
Other
Stock Options
2021-06-10+755→ 477,870 total
Exercise: $21.60From: 2019-01-23Exp: 2023-06-10→ Common Stock (755 underlying)
Other
Stock Options
2021-06-10+298,320→ 477,870 total
Exercise: $2.48From: 2020-12-29Exp: 2023-06-10→ Common Stock (298,320 underlying)

Footnotes (3)

[F1]Expiration date of the stock options was extended to June 10, 2023.
[F2]7,338 of the stock options vest immediately. 4,077 of the stock options vest on each of 2/25/2015 and 2016 and 4,076 of the stock options vest on 2/25/2017.
[F3]In connection with the Reporting Person's separation agreement dated December 21, 2020, the Compensation Committee accelerated the vesting of such stock options to December 29, 2020.

Documents

1 file

4
wf-form4_162370142446711.xmlPrimary
FORM 4

Issuer

Cardiff Oncology, Inc.

CIK 0001213037

Entity typeother

Related Parties

1

filerCIK 0001234366

Filing Metadata

Form type: 4
Filed: Jun 13, 8:00 PM ET
Accepted: Jun 14, 4:10 PM ET
Size: 18.1 KB

View on SEC.gov